Medicare Enrolled
Dr. Amit Barochia, MD
Hematology · Melbourne, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barochia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barochia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barochia
Dr. Amit Barochia is a hematology specialist in Melbourne, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Barochia performed 190,429 Medicare services across 3,886 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barochia received a total of $6,052 from 53 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barochia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 23% volume in FL
$6,052 industry payments
Medicare Practice Summary
Medicare Utilization ↗190,429
Medicare services
Top 23% in FL for hematology
3,886
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,579 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
36,210 | $0 | $3 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
36,000 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 25,600 | $42 | $105 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
14,934 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
14,700 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 12,540 | $18 | $45 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
12,000 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
9,380 | $6 | $21 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
7,980 | $36 | $89 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
4,710 | $10 | $42 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,540 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,362 | $92 | $255 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,660 | $1 | $27 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
696 | $10 | $42 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
684 | $81 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 676 | $0 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
639 | $22 | $57 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
626 | $133 | $358 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
561 | $97 | $256 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
534 | $46 | $133 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 433 | $134 | $1,054 |
| Injection, fulvestrant, 25 mg | 400 | $8 | $161 |
| Injection, potassium chloride, per 2 meq | 380 | $0 | $0 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
294 | $15 | $41 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
281 | $1 | $3 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
272 | $54 | $142 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
260 | $1 | $2 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
256 | $93 | $235 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
251 | $12 | $36 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
188 | $62 | $157 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
186 | $25 | $66 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
178 | $65 | $180 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
157 | $2 | $6 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
152 | $1 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
144 | $114 | $335 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
143 | $19 | $52 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
142 | $134 | $361 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
139 | $21 | $56 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
129 | $6 | $29 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
115 | $18 | $50 |
| New patient office visit, complex (60-74 min) | 105 | $171 | $442 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
97 | $10 | $25 |
| Leukocyte-reduced red blood cell unit A unit of red blood cells that has been processed to remove white blood cells (leukocytes) before transfusion. |
97 | $67 | $564 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
95 | $49 | $127 |
| Blood or blood product transfusion The administration of whole blood or specific blood components into a patient's bloodstream. |
91 | $29 | $76 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
78 | $24 | $96 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
65 | $65 | $190 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
58 | $14 | $37 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
56 | $4 | $13 |
| Injection, alteplase recombinant, 1 mg | 52 | $69 | $177 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
50 | $42 | $109 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
22 | $24 | $64 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
16 | $270 | $700 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $103 | $266 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
45.9% high complexity
51.5% medium
2.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,052
Total received (2018-2024)
Avg $865/year across 7 years
Bottom 44% in FL for hematology
53
Companies
298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,387 (89.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$664 (11.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$141
2023
$202
2022
$1,036
2021
$1,213
2020
$1,174
2019
$1,369
2018
$917
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$658
Amgen Inc.
$651
AstraZeneca Pharmaceuticals LP
$464
Celgene Corporation
$401
PFIZER INC.
$375
Seagen Inc.
$295
Merck Sharp & Dohme Corporation
$280
Lilly USA, LLC
$256
Janssen Biotech, Inc.
$246
GENZYME CORPORATION
$187
Bayer HealthCare Pharmaceuticals Inc.
$180
Daiichi Sankyo Inc.
$179
Genentech USA, Inc.
$173
Cardiovascular Systems Inc.
$152
E.R. Squibb & Sons, L.L.C.
$149
Incyte Corporation
$142
Kite Pharma, Inc.
$124
Novocure Inc.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$83
TOLMAR Pharmaceuticals, Inc.
$55
Global Blood Therapeutics, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
ARRAY BIOPHARMA INC
$46
EISAI INC.
$45
Astellas Pharma US Inc
$45
MorphoSys, US Inc.
$45
Pharmacyclics LLC, An AbbVie Company
$43
Sun Pharmaceutical Industries Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$33
Kyowa Kirin, Inc.
$31
Regeneron Healthcare Solutions, Inc.
$30
Jazz Pharmaceuticals Inc.
$28
JAZZ PHARMACEUTICALS INC.
$27
Sobi, Inc
$27
ADC Therapeutics America, Inc.
$26
Gilead Sciences, Inc.
$24
TESARO, Inc.
$23
Verastem, Inc.
$23
Mirati Therapeutics, Inc.
$21
Myriad Genetic Laboratories, Inc.
$20
Pharmacosmos Therapeutics Inc.
$18
BeiGene USA, Inc.
$18
Clovis Oncology, Inc.
$17
Taiho Oncology, Inc.
$17
EMD Serono, Inc.
$17
Dendreon Pharmaceuticals LLC
$17
Seattle Genetics, Inc.
$16
Exelixis Inc.
$15
Ipsen Biopharmaceuticals, Inc
$15
GlaxoSmithKline, LLC.
$15
Puma Biotechnology, Inc.
$14
Janssen Pharmaceuticals, Inc
$13
Paratek Pharmaceuticals, Inc.
$12
Top 3 companies account for 29.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · ELIGARD · ELITEK · ENHERTU · ERBITUX · ERLEADA · Enhertu · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · Monoferric · NERLYNX · NINLARO · NUZYRA · Nerlynx · Nplate · Nubeqa · OPDIVO · OXBRYTA · Optune · PADCEV · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · Phesgo · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIVDAK · TUKYSA · VERZENIO · VOTRIENT · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
10
Per 100K population
1.6
County median income
$75,817
Nearest hospital
VIERA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Barochia is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Barochia experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Barochia performed 36,210 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barochia receive payments from pharmaceutical companies?
Yes. Dr. Barochia received a total of $6,052 from 53 companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barochia's costs compare to other hematologists in Melbourne?
Dr. Barochia's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barochia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Melbourne
Browse hematologists in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology